Patients
For patients, management of a rare disease can be all-consuming. At MBX Biosciences, we are dedicated to making meaningful improvements in patients’ lives by minimizing their daily burden.
Through our innovative research, discovery, and development of novel therapeutics, we aim to change the therapeutic landscape for those living with hypoparathyroidism, post-bariatric hypoglycemia and other rare and/or prevalent diseases.
Daily, and often hourly, management is part of these rare and deadly diseases that have little to no effective treatment options. We are striving to offer new hope.
Patient Stories
“The diagnosis is overwhelming, then you find out it’s rare, and only then do you find out the severity of what hypoparathyroidism is and it’s nothing to be glossed over.”
“No two people with this disease have an identical experience. They may be similar, but not identical, so management and understanding can be difficult.”
“Living with HP is a life changer. Most doctors aren’t given the opportunity to spend more than one day in medical school learning about HP, so you have to do your homework and be your own advocate.”
Resources & Advocacy
Low levels of the parathyroid hormone (PTH) lead to dangerously low levels of calcium with increased phosphorus, which can quickly lead to tetany (painful muscle spasms), heart palpitations and more, including death. Additionally, complications are numerous.
Most patients describe hypoparathyroidism as a self-managed disease due to how little many doctors know about it and understand it. MBX 2109 is currently in clinical trials, paving the way towards a new approach for patients and physicians alike.
Patient Resources
Many consider hypoparathyroidism as a loss of regular life due to the inability to continue many typical activities coupled with the need for constant symptom and medication monitoring. Community is a high valued resource for both education and comradery.
We are constantly working with patients and advocacy groups to learn about the challenges patients experience in their daily lives and how we can best support them from a therapeutic perspective and beyond.
For questions or interest in participating in our clinical trials, please email us.
[email protected]